FilingSEC EDGAR6-K
Psyence Biomedical Enters Into Strategic Investment and Share Exchange Agreement with Psyence Labs
· SEC accepted
StageContract Signed
Filing content
Psyence Biomedical has agreed to invest up to $5 million in Psyence Labs and conduct a share exchange to support its planned U.S. ibogaine clinical program.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…